Relic Technologies Appoints Sachin Srivastava as New CEO, Karthik Iyer Resigns

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Relic Technologies Appoints Sachin Srivastava as New CEO, Karthik Iyer Resigns

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Relic Technologies has appointed Sachin Srivastava as its new Whole Time Director and CEO, effective June 13, 2026. The company also announced the resignation of Executive Director Karthik Iyer on the same date.

Relic Technologies Appoints Sachin Srivastava as CEO, Sees Board Resignation

Relic Technologies Limited announced significant leadership changes, appointing Mr. Sachin Srivastava as Whole Time Director and Chief Executive Officer (CEO) and accepting the resignation of Mr. Karthik Iyer as Executive Director. Both changes are effective June 13, 2026.

What just happened

Relic Technologies has appointed Sachin Srivastava as its new Whole Time Director and CEO. Concurrently, Karthik Iyer has resigned from his position as Executive Director.

Why this matters

These leadership changes signal a strategic shift for Relic Technologies, with a new CEO expected to drive profitability and market share. Investors will be watching for how the new leadership executes strategic objectives.

The backstory

Sachin Srivastava brings almost 25 years of experience in pharmaceutical sales, marketing, team building, and organizational strategy. Karthik Iyer has stepped down citing personal and health reasons.

What changes now

The appointment of Mr. Srivastava is expected to bring a renewed focus on operational efficiency, brand building, and market expansion. The board composition will also change with Mr. Iyer's departure.

Risks to watch

Leadership transitions can sometimes create short-term uncertainty. Investors will need to monitor the integration of the new CEO and the company's performance under the new management.

Peer comparison

[Company] operates within the pharmaceutical sector. Leadership changes are common as companies adapt to market dynamics and strive for growth, similar to peers.

Context metrics (time-bound)

Both leadership changes are effective from June 13, 2026.

What to track next

Investors should track the company's strategic announcements, financial performance, and market share developments under the new CEO's leadership.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.